For the Culture By The Culture
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
Increasing tariffs and trade policies are driving up prices for cannabis accessories, impacting consumers who face strategic price hikes disguised as inflation. Major corporations pass these costs to customers while small producers struggle. The industry’s silence on these issues highlights economic manipulation, urging consumers to support local brands and demand transparency.
